About ANNOVIS BIO INC
Annovis Bio is a Phase 3 clinical-stage company developing transformative therapies for neurodegenerative diseases such as Alzheimer’s and Parkinson’s. The company focuses on restoring nerve cell function and improving cognitive and motor abilities in patients.
Developing therapies for neurodegenerative diseasesRestoring nerve cell functionImproving cognitive and motor abilitiesConducting clinical trials for Alzheimer’s and Parkinson’s disease
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ANNOVIS BIO INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.